Mark Kozloff to TNF-Related Apoptosis-Inducing Ligand
This is a "connection" page, showing publications Mark Kozloff has written about TNF-Related Apoptosis-Inducing Ligand.
Connection Strength
0.455
-
A phase 1B study of dulanermin in combination with modified FOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer. Clin Colorectal Cancer. 2013 Dec; 12(4):248-54.
Score: 0.455